Key takeaways
- Androgen receptors are densely expressed in the hippocampus, prefrontal cortex and amygdala, and observational studies consistently link low testosterone to worse memory and slower processing speed.
- Men who report feeling sharper on treatment are most likely experiencing better sleep, mood and fatigue rather than a direct cognitive effect.
- Two well-conducted randomised, placebo-controlled trials tested this directly in older men with low testosterone.
- Low testosterone is associated with higher Alzheimer's incidence in observational cohorts, and mechanistic work offers pathways by which sex steroids could plausibly influence amyloid handling and neuroinflammation.
- Brain fog is a real symptom that deserves a real workup rather than a single hormone.
"Brain fog" is one of the most common things men report alongside low testosterone, and one of the most commonly overpromised. The mechanism is genuinely there — androgen receptors are distributed through the memory and executive regions of the brain, and the associations in observational data are consistent. But when the question was put to properly randomised trials, the results did not go the way the mechanism predicted. This article covers both halves, because a page that only reports the first half is not describing what the research shows.
Why the mechanism is plausible
Androgen receptors are expressed throughout the human brain, with notable density in regions that matter for exactly the complaints men describe:
- Hippocampus — the formation and consolidation of new memories
- Prefrontal cortex — executive function, working memory, planning, holding a complex problem in mind
- Amygdala — emotional salience and threat processing
- Hypothalamus — the endocrine and autonomic integration layer
- Brainstem — arousal and alertness
Testosterone reaches these regions and acts through several routes at once. It binds androgen receptors directly; it converts locally to dihydrotestosterone, a more potent androgen; and it aromatises to estradiol, which acts at estrogen receptors with its own well-characterised effects on synaptic plasticity and neuroprotection. Preclinical work links these signals to neurogenesis, dendritic branching, reduced neuroinflammation and mitochondrial function (androgen receptor expression in the human brain).
None of that is controversial. It is a good reason to run the trial. It is not a result.
What the observational data shows
Cross-sectional and cohort studies have repeatedly found lower testosterone associated with worse performance on verbal memory, processing speed and spatial cognition, with more subjective cognitive complaints, and with higher long-term incidence of Alzheimer's disease.
The interpretation problem is severe and worth stating rather than glossing. Testosterone declines with age; cognition declines with age. Low testosterone is also a marker of poor sleep, obesity, sleep apnoea, depression, chronic illness and low physical activity — every one of which independently impairs cognition. An association between low testosterone and worse memory is exactly what you would expect to see whether or not testosterone is doing anything to memory at all.
That is the whole reason randomised trials exist.
What the randomised trials found
Two well-conducted randomised, placebo-controlled trials tested this directly in older men with low testosterone. Both were null.
The Cognitive Function Trial, part of the Testosterone Trials, enrolled older men with low testosterone and age-associated memory impairment — the population most likely to show a benefit if one existed. After a year of treatment versus placebo, testosterone did not improve memory or other cognitive function (Resnick et al., JAMA 2017).
The TEAAM trial ran longer — three years of testosterone administration in older men with low or low-to-normal testosterone — and its prespecified cognitive analysis reached the same conclusion: no significant improvement in cognitive measures versus placebo (Huang et al., Lancet Diabetes Endocrinol 2016).
Two trials, different durations, different designs, same answer. That is a considerably stronger evidentiary position than a single null result, and it is the finding that should anchor expectations.
The honest position: the mechanism is real, the observational associations are real, and the randomised evidence that testosterone improves cognition in older men is negative. A site that sells hormone therapy has an obvious incentive to report the first two and omit the third. If mental sharpness is your main reason for pursuing treatment, you should know that this is the one outcome the best trials looked for and did not find.
So why do men report feeling sharper?
They do report it, consistently, and dismissing that as imagination is no more honest than presenting it as proven cognition enhancement. Several explanations fit the evidence better than a direct cognitive effect:
- Sleep. Testosterone is largely produced during sleep, and low testosterone frequently travels with fragmented sleep. Anything that improves sleep improves attention, working memory and processing speed — and none of that requires a direct effect on neurons.
- Mood. Randomised evidence supports a reduction in depressive symptoms with testosterone treatment. Depression impairs concentration and memory retrieval. Lifting mood lifts cognitive performance without changing cognitive capacity.
- Energy and fatigue. Mental stamina at 4 p.m. is not the same construct as memory, and it is the one most men are actually describing when they say their head is clearer.
- Expectation. Most men experience treatment unblinded, having decided in advance that it will help. That is precisely the effect a placebo arm exists to subtract, and in these trials, subtracting it removed the benefit.
The distinction is not academic. If the improvement comes through sleep, mood and fatigue, then sleep, mood and fatigue are the things to measure and to address — including in men whose testosterone is entirely normal.
Alzheimer's risk: an open question, not a claim
Low testosterone is associated with higher Alzheimer's incidence in observational cohorts, and mechanistic work offers pathways by which sex steroids could plausibly influence amyloid handling and neuroinflammation. Whether treatment modifies that risk has not been established, and given that the shorter-term cognitive trials were null, extrapolating to neurodegenerative protection is not currently supportable. It is a reasonable research question and it should be described as one.
What to do about cognitive complaints
Brain fog is a real symptom that deserves a real workup rather than a single hormone. Worth evaluating:
- Sleep, first and most — including screening for obstructive sleep apnoea, which is common, treatable, and produces exactly this presentation
- Thyroid function, where hypothyroidism is a classic and correctable cause
- B12, ferritin and vitamin D, all of which are cheap to check and consequential when low
- Glucose handling — fasting glucose, insulin and HbA1c; insulin resistance affects cognition
- Depression and anxiety, assessed properly rather than assumed away
- Medications and alcohol, the most commonly overlooked contributors
- Hormones, including total and free testosterone with SHBG, as one input among these — not as the answer before the others have been asked
Bottom line
Testosterone acts in the brain regions responsible for memory and executive function, and men with low testosterone perform worse on cognitive testing in observational studies. But two randomised placebo-controlled trials — one in men selected for memory impairment, one running three years — both failed to show cognitive improvement with treatment. The mechanism is real; the demonstrated cognitive benefit is not. Men who feel sharper on treatment are most likely experiencing improvements in sleep, mood and fatigue, which are worth having on their own terms and are worth pursuing whatever your testosterone happens to be. Treat cognitive symptoms as a workup, not as a hormone question with a foregone conclusion.
Educational content, not medical advice. Laboratory interpretation and any treatment decision are made by a licensed physician after individual evaluation. Individual results vary.
